Patent 7243112 was granted and assigned to Rigel Pharmaceuticals on July, 2007 by the United States Patent and Trademark Office.
This invention provides an advanced platform for the analysis of biological data that emphasizes pathway mapping and relationship inference based upon data acquired from multiple diverse sources. The platform employs a bioinformatic system that integrates data from the diverse sources, connecting related genes and proteins and inferring biological functions in the context of global cellular processes.